Bio-Path Holdings Files 8-K
Ticker: BPTH · Form: 8-K · Filed: May 30, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | May 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K on May 30th for an event on May 23rd. Check for details.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on May 30, 2024, reporting an event on May 23, 2024. The filing is a current report under Regulation FD and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Bellaire, Texas.
Why It Matters
This 8-K filing indicates a significant event or update from Bio-Path Holdings, Inc. that is being disclosed to the public, potentially impacting investors.
Risk Assessment
Risk Level: low — This filing is a standard 8-K current report and does not inherently indicate significant financial distress or unusual risk.
Key Numbers
- 001-36333 — SEC File Number (Identifier for Bio-Path Holdings, Inc.)
- 87-0652870 — IRS Employer Identification No. (Tax identification for Bio-Path Holdings, Inc.)
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- May 23, 2024 (date) — Earliest event date
- May 30, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Bellaire, Texas (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing does not specify the exact event, only that it is a current report filed on May 30, 2024, with the earliest event date being May 23, 2024.
What is the primary business of Bio-Path Holdings, Inc.?
Bio-Path Holdings, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Where are Bio-Path Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
When is Bio-Path Holdings, Inc.'s fiscal year end?
The fiscal year end for Bio-Path Holdings, Inc. is December 31st.
What is the SEC file number for Bio-Path Holdings, Inc.?
The SEC file number for Bio-Path Holdings, Inc. is 001-36333.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-05-30 16:10:23
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240523x8k.htm (8-K) — 40KB
- bpth-20240523xex99d1.htm (EX-99.1) — 17KB
- bpth-20240523xex99d2.htm (EX-99.2) — 13KB
- bpth-20240523xex99d1001.jpg (GRAPHIC) — 11KB
- bpth-20240523xex99d2001.jpg (GRAPHIC) — 11KB
- 0001558370-24-008779.txt ( ) — 227KB
- bpth-20240523.xsd (EX-101.SCH) — 3KB
- bpth-20240523_lab.xml (EX-101.LAB) — 16KB
- bpth-20240523_pre.xml (EX-101.PRE) — 10KB
- bpth-20240523x8k_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On May 23, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release titled, "Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting." A copy of such press release is attached hereto as Exhibit 99.1. On May 24, 2024, the Company issued a press release titled, "Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress." A copy of such press release is attached hereto as Exhibit 99.2.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated May 23, 2024. 99.2 Press release dated May 24, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: May 30, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer